Innoviva, Inc. (INVA)

NASDAQ: INVA · USD

$21.1

+0.12 (+0.6%)· Recorded snapshot

Market cap	1.5B
Revenue (ttm)	440M
Net income (ttm)	357.2M
EPS (ttm)	$4.31
Shares out	72.2M
P/E (trailing)	4.9x
P/E (forward)	10.9x
Volume	430,823
Beta	0.38

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 440M
Net income (ttm): 357.2M
EPS (ttm): $4.31
P/E (trailing): 4.9x
P/E (forward): 10.9x
Market cap: 1.5B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E10.9

P25 n/aP50 n/aP75 n/a

Trailing P/E4.9

P25 n/aP50 n/aP75 n/a

ROE36.7

P25 n/aP50 n/aP75 n/a

ROIC14.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All INVA indicators

Market & fundamental data

Available fields

271

Groups with data

Currency

USD

Showing 271 of 271 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001080014
Company name	Innoviva, Inc.
Country	United States
Country code	US
CUSIP number	45781M101
Earnings date	2026-11-09
Earnings time	amc
Employees	159
Employees change	32
Employees growth	25.2%
Enterprise value	$1.3B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1996
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2004-10-05
Is primary listing	Yes
Is SPAC	No
ISIN number	US45781M1018
Last 10-K release date	2026-02-25
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.5B
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$21.06
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	INVA
U.S. state	California
Website	https://www.inva.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	11.19x
Average P/E ratio (10Y)	10.1x
Average P/E ratio (3Y)	14.13x
Average P/E ratio (5Y)	10.27x
Earnings yield	20.46%
EV/Earnings	3.57x
EV/EBIT	7.55x
EV/EBITDA	6.53x
EV/FCF	6.73x
EV/Sales	2.9x
FCF / EV yield	14.86%
FCF yield	12.44%
Forward EV/Sales	2.72x
Forward P/E	10.94x
Forward P/S	3.24x
Graham number	40.57029
Graham upside	92.46%
Lynch fair value	$26.45
Lynch upside	25.5%
P/(FCF - SBC) ratio	8.59x
P/(OCF - SBC) ratio	8.49x
P/B ratio	1.23x
P/E ratio	4.89x
P/FCF ratio	8.04x
P/OCF ratio	7.95x
P/S ratio	3.46x
PEG ratio	3.62x
Price / tangible book value	1.46x
Price/EBITDA ratio	7.79x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	38.36%
EBITDA margin	44.41%
Effective tax rate	14.82%
FCF margin	43.06%
Gross margin	72.67%
Operating margin	38.36%
Pretax margin	95.32%
Profit margin	81.19%
Profit per employee	$2.2M
Profitable years	10
Revenue per employee	$2.8M
ROA	6.95%
ROA (5Y)	12.02%
ROCE	10.19%
ROE	36.68%
ROE (5Y)	33.38%
ROIC	14.05%
ROIC (5Y)	21.12%
SBC / revenue	2.77%
Tax / revenue	14.13%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	708.3%
EPS growth 10Y	38.6%
EPS growth 3Y	17.64%
EPS growth 5Y	11.99%
EPS growth years	1
FCF growth	-5.44%
FCF growth (Q)	16.95%
FCF growth (QoQ)	48.15%
FCF growth 3Y	28.94%
FCF growth 5Y	-10.43%
Gross profit growth	-1.57%
Gross profit growth (Q)	8.93%
Gross profit growth 3Y	11.32%
Gross profit growth 5Y	-2.57%
Net income growth	824.31%
Net income growth 3Y	15.25%
Net income growth 5Y	6.14%
Net income growth years	1
OCF growth	-4.55%
OCF growth (Q)	17.92%
OCF growth (QoQ)	47.3%
OCF growth 10Y	20.66%
OCF growth 3Y	29.36%
OCF growth 5Y	-10.23%
Operating income growth	-6.59%
Operating income growth (Q)	5.3%
Operating income growth 3Y	7.94%
Operating income growth 5Y	-13.42%
Revenue growth	18.85%
Revenue growth (Q)	19.25%
Revenue growth (QoQ)	22.04%
Revenue growth 10Y	16.81%
Revenue growth 3Y	14.85%
Revenue growth 5Y	3.78%
Revenue growth quarters	12
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-2.1M
Depreciation and amortization	$26.6M
EBIT	$168.8M
EBITDA	$195.4M
EPS	$4.31
FCF per share	$2.62
Financing cash flow	$-42.4M
Free cash flow	$189.4M
Free cash flow minus SBC	$177.2M
Gross profit	$319.8M
Income taxes	$62.2M
Investing cash flow	$23.8M
Net borrowing	$-25,000
Net cash flow	$172.9M
Net income	$357.2M
Operating cash flow minus SBC	$179.3M
Operating income	$168.8M
Revenue	$440M
Stock-based compensation	$12.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.27
Book value per share	$16.98
Debt / EBITDA	1.68
Debt / equity	0.27
Debt / FCF	1.75
Goodwill	$17.9M
Interest coverage	9.26
Long-term assets	$949.4M
Long-term liabilities	$422.4M
Net cash (debt)	$247.8M
Net cash / market cap	16.27%
Net debt / EBITDA	-1.27
Net debt / equity	-0.2
Net debt / FCF	-1.31
Piotroski F-Score	6
Property, plant and equipment	$12.5M
Shareholders' equity	$1.2B
Tangible book value	$1B
Tangible book value per share	$14.41
Total assets	$1.7B
Total cash	$579.1M
Total debt	$331.2M
Total liabilities	$469.5M
WACC	6.06%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.29
Current assets	$753.4M
Current liabilities	$47.1M
Current ratio	16.01
Inventory turnover	2.73
Net working capital	$134.3M
Quick ratio	14.65
Working capital	$706.3M
Working capital turnover	0.79

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.03%
Dividend per share	$0.00
Dividend yield	0%
Last dividend	$0.25
Shareholder yield	-0.03%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	117.74%
10Y return CAGR	8.09%
10Y total return	117.74%
150-day SMA	$21.93
15Y price change	-10.68%
15Y return CAGR	1.17%
15Y total return	19.09%
1D price change	0.57%
1M price change	1.21%
1M total return	1.21%
1W price change	-1.36%
1W total return	-1.36%
1Y price change	18.45%
1Y return CAGR	18.47%
1Y total return	18.45%
20-day SMA	$20.92
200-day SMA	$21.87
20Y price change	-35.73%
20Y return CAGR	-0.77%
20Y total return	-14.31%
3M price change	-1.46%
3M total return	-1.46%
3Y price change	70.37%
3Y return CAGR	19.43%
3Y total return	70.37%
50-day SMA	$20.99
50-day SMA vs 200-day SMA	50under200
52-week high	$25.15
52-week high date	2026-02-26
52-week low	$17.45
52-week low date	2025-10-29
5Y price change	30.37%
5Y return CAGR	5.45%
5Y total return	30.37%
6M price change	-10.15%
6M total return	-10.15%
All-time high	$42.96
All-time high date	2013-07-12
All-time low	$4.32
All-time low date	2008-11-21
Average true range (ATR)	$0.47
Average volume	639.2K
Beta (1Y)	-0.14
Beta (2Y)	0.14
Beta (5Y)	0.38
Change from 52-week high	-16.25%
Change from 52-week low	20.69%
Change from all-time high	-51.14%
Change from all-time low	385.88%
Change from open	1.45%
Day's gap	-0.86%
Dollar volume	$9.1M
High price	$21.09
Low price	$20.75
Monthly RSI	54.18
Open price	$20.76
Position in 52-week range	91.18%
Premarket change	-0.91%
Premarket close	$20.94
Premarket price	$20.75
Previous close	$20.94
Price vs 150-day SMA	-4.27%
Price vs 20-day SMA	0.33%
Price vs 200-day SMA	-4.02%
Price vs 50-day SMA	0.02%
Relative volume	0.67
RSI	50.41
Sharpe ratio	0.61
Sharpe ratio (3Y)	0.66
Sharpe ratio (5Y)	0.17
Sortino ratio	1.24
Sortino ratio (3Y)	1.33
Sortino ratio (5Y)	0.48
Volume	430.8K
Weekly RSI	47.82
YTD price change	5%
YTD total return	5%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	67.7M
Float percentage	93.64%
Shares change (QoQ)	-13.47%
Shares change (YoY)	0.03%
Shares held by insiders	0.75%
Shares held by institutions	101.82%
Shares outstanding	72.2M
Short % of float	10.12%
Short % of shares	9.48%
Short ratio	6.8 days

Deeper analysis on INVA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this INVA report

Is a complete INVA research report available?

No complete published report is available for Innoviva, Inc. (INVA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Innoviva, Inc. (INVA)

Price

Financial snapshot

Fair-value bridge

Latest news · INVA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INVA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on INVA

Frequently asked questions